The effects of the tricyclic antidepressant clomipramine on sleep EEG and nocturnal penile tumescence (NPT) were investigated during a long-term study in a normal male control subject. During 21 consecutive days the subject received first placebo for 3 days, then stepwise increasing dosages of clomipramine for 10 days, and finally placebo after withdrawal for 8 days. Under clomipramine, rapid eye movement (REM) sleep was suppressed markedly; an REM rebound occurred after withdrawal. Awake and stages 1 and 2 increased while slow wave sleep was diminished under clomipramine. Those non-REM parameters returned to baseline values after drug cessation. NPT was reduced simultaneously with REM sleep under clomipramine 30 to 75 mg. Under this dosage range, full erections occurred during the later hours of sleep in association with the delayed REM periods. Clomipramine 100 mg prompted a further decrease of NPT, which exceeded the REM suppression. Most of the changes and NPT parameters depended significantly on the dosage and the plasma concentration of clomipramine. After withdrawal, NPT needed 6 days to normalize. Although NPT was disturbed distinctly, no erectile dysfunction, but a decrease of sexual interest and, once, a lack of ejaculation, were reported.
Download full-text PDF |
Source |
---|
Neuropsychiatr Dis Treat
October 2024
Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Clin Neuropharmacol
November 2023
Department of Neurology, Medical College of Wisconsin, Milwaukee.
In persons with narcolepsy type 1, sudden withdrawal of antidepressants can cause status cataplecticus. We describe a 77-year-old female patient with long-standing history of narcolepsy type 1 complaining of recurrent short sudden episodes of whole-body paralysis, with preserved consciousness and memory. Episodes started an hour after her family invited her to celebrate Mother's Day.
View Article and Find Full Text PDFEur J Investig Health Psychol Educ
August 2023
Facultad de Ciencias Jurídicas y Sociales, Universidad Simón Bolívar, Cúcuta 540001, Colombia.
This review aimed to investigate the metabolic alterations associated with psychopharmacological treatment of neuropsychiatric disorders, which can significantly impact patients' physical health and overall quality of life. The study utilized the PRISMA methodology and included cross-sectional, retrospective studies, and randomized clinical trials from reputable databases like SCOPUS, CLARIVATE, SCIENCE DIRECT, and PUBMED. Out of the 64 selected studies, various psychotropic drug classes were analyzed, including antidepressants, anticonvulsants, and antipsychotics.
View Article and Find Full Text PDFInt J Endocrinol Metab
January 2022
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institude, Shariati Hospital, Tehran University of Medical Sciences,Tehran, Iran.
Introduction: Addison disease is a relatively uncommon endocrine disease resulting from adrenal insufficiency. Psychiatric symptoms are among its rare primary and particularly isolated clinical symptoms. This report presents a case with adrenal insufficiency manifested by the psychotic syndrome.
View Article and Find Full Text PDFIntern Med
October 2022
Department of Neurology, Nagoya University Graduate School of Medicine, Japan.
A 57-year-old man presented with difficulty speaking and walking along with increased daytime somnolence. His symptoms fluctuated throughout the day but never completely disappeared. A neurological examination revealed mild dysarthria, limb weakness, and staggering gait.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!